What Feedback and Opinions Are Emerging on the New 2024 ESC Guidelines?
In this exclusive video, we bring you insights from top experts -Prof. Dudek, Prof. Colombo, and Dr. Testa- on the newly released 2024 ESC guidelines.
Which are the Advantages of DCB over DES?
Explore expert insights into the advantages of DCBs over DES in this exclusive video featuring Prof. Dudek and Dr. Testa
DCBs: When to use them? Real cases as example
Discover when Drug-Coated Balloons (DCBs) can make a difference in patient care with insights from Prof. Colombo.
DCBs: How to use them?
Discover Prof. Colombo as he provides a comprehensive guide on effectively using DCBs in clinical practice, including valuable insights into lesion preparation.
Current and Expanding Applications of DCBs
Explore the current and expanded applications of Drug-Coated Balloons (DCBs) with insights from Prof. Dudek.
Angio vs. FFR in DCB: DCB or DES? An FFR Perspective
Join Dr. Eccleshall as he explores the critical debate of Angiography versus FFR in the context of DCBs versus DES.
Clinical Outcomes on Sirolimus-based DCBs vs Paclitaxel-based DCBs
Join Dr. Testa as he presents a detailed comparison of clinical outcomes between Sirolimus-based and Paclitaxel-based DCBs.
The role of DCB today and tomorrow in the management of Vascular Access Occlusions
The Drug Coating Balloons’ role in the treatment of vascular access occlusion is undergoing rapid transformation. In this comprehensive review, Dr. Kitrou from Patras University in Greece elucidates the present and prospective applications of this technology in this specific medical context.
The Aperto® OTW Clinical Outcome and Cost / Benefit implication
Aperto® OTW is a specialized device designed for the management of vascular access occlusion. In a clinical perspective, Professor Tozzi from Insubria Varese University in Italy presents his personal experience with this device, while also considering its cost-benefit implications.
From theory to practice: my personal algorithm in the treatment of Vascular Access Occlusions
The DCB application on the vascular access occlusions management is quickly changing. Thanks his expertise Dr Robert Shahverdyan share his personal approach and rational on the management of such lesions presenting also some practical cases.
Vessel Preparation before DCB use in the Femoro-popliteal district
In the present day, the preparation of vessels assumes a crucial role prior to the utilization of DCBs. During the Cardionovum® workshop held at the Granollers Hospital, Dr. Sirvent will delve into this subject, presenting a comprehensive overview and sharing his personal experience in the treatment of Fermoro-popliteal lesions.
Tools available for the BTK treatment
During the Cardionovum® workshop held at the Granollers Hospital, a specific focus was dedicated to the treatment of Below The Knee (BTK) lesions. The available tools are diverse, and Dr. Sirvent presented a personal algorithm and approach for the treatment of this intricate area.
Slow flow after BTK interventions:is Paclitaxel the guilty?
Slow Flow” or "No Flow" is becoming more and more an hot topic, especially during the treatment of the most distal leg lesions.
Nowadays this phenomenon is associated generically to the use of Paclitaxel Drug Coated Balloons; but is the Paclitaxel the guilty? In reality not all the DCBs are the same and let’s discover the technological differences with this interesting speech of Dr. Marc Sirvent.
Nowadays this phenomenon is associated generically to the use of Paclitaxel Drug Coated Balloons; but is the Paclitaxel the guilty? In reality not all the DCBs are the same and let’s discover the technological differences with this interesting speech of Dr. Marc Sirvent.
